Why Do Vaccine Efficacy Rates Differ?
Emeritus Professor Dr P.T. Thomas, Executive Dean, Faculty of Health and Medical Sciences, Taylor's University
15-Jan-21 07:47
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Pharmaniaga has inked a deal with Chinese biotech firm Sinovac to fill and finish 14 million doses of Covid-19 for Malaysians. But with questions starting to emerge over the efficacy of the Sinovac vaccine, we speak to Emeritus Professor Dr P.T. Thomas, Executive Dean at the Faculty of Health and Medical Sciences, Taylor's University, to help us understand vaccine approvals and some of the data coming out of different countries.
Image Credit: Shutterstock.com
Produced by: Shazana Mokhtar
Presented by: Lyn Mak, Noelle Lim, Roshan Kanesan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories:
Tags: covid-19, vaccine, sinovac, efficacy rates, NPRA
